Anticoagulant-Induced Skin Necrosis
Anticoagulant-induced skin necrosis is a rare but very serious complication that usually develops early in treatment with vitamin K antagonists (such as warfarin) or heparins. Blood clots form inside the small vessels of the skin, cutting off the blood supply and causing tissue to die suddenly.
At Haute-Derma, we treat this as a medical emergency. Our priorities are to recognize the first signs immediately, work with the prescribing team to stop the offending drug, and use tissue-preserving measures to keep the area of necrosis, and the chance of needing surgery, as small as possible.
Our Approach at Haute-Derma
Our specialists focus on catching early warning signs during the window between day 3 and day 10 after the drug is started:
- Early stage: Intense burning pain in one specific area of skin, followed by poorly defined redness.
- Progression: The red area turns purple, hemorrhagic blisters form, and it quickly becomes a dry, black, hard crust of dead tissue (eschar).
- Typical sites: Areas with plenty of subcutaneous fat, such as the breasts, thighs, buttocks, and abdomen, where the small blood vessels are especially vulnerable to an imbalance in clotting.
At Haute-Derma, we understand how frightening it is to see your skin suddenly change color and become painful. Our multidisciplinary process makes sure clotting is corrected at the same time as the wound receives specialized care.
Causes and High-Risk Groups
Haute-Derma carefully reviews each patient's risk factors:
- Protein C or protein S deficiency: The most common inherited factor that predisposes patients to necrosis on warfarin.
- Excessive loading dose: Starting anticoagulation at a high dose without an adequate heparin overlap.
- Heparin-induced thrombocytopenia (HIT): An immune reaction to heparin that causes widespread clotting.
How We Diagnose Anticoagulant-Induced Skin Necrosis at Haute-Derma
We follow an urgent assessment pathway:
- Clinical and timeline assessment: Establishing a direct link between the medication and lesions in fatty areas.
- Coagulation tests: INR, protein C and protein S levels, and a platelet count to screen for HIT.
- Skin biopsy: Performed at Haute-Derma to look for clots in the venules and capillaries without accompanying vasculitis.
- Doppler ultrasound: Assesses blood flow to the surrounding tissue to predict how far the necrosis may spread.
Specialized Treatment of Anticoagulant-Induced Skin Necrosis at Haute-Derma
Our protocol aims to restore blood flow and save as much tissue as possible:
- Stop the drug immediately: The suspected warfarin or heparin is discontinued and replaced with a safer alternative anticoagulant (such as fondaparinux or a newer oral anticoagulant, NOAC).
- Correct the clotting imbalance: Intravenous vitamin K plus fresh frozen plasma or protein C concentrate is given to reverse the temporary deficiency.
- Rest and elevation: Patients are encouraged to avoid strenuous activity and keep the legs raised to reduce hydrostatic pressure on the capillaries.
- Wound care for necrotic areas:
- Negative-pressure wound therapy (VAC) to encourage healthy granulation tissue.
- Conservative debridement of dead tissue to protect the healthy structures underneath.
- Hyperbaric oxygen therapy: May be offered at Haute-Derma's partner facilities to deliver more oxygen to the oxygen-starved tissue.
